The University of Chicago Header Logo

Connection

John Moroney to Paclitaxel

Back to Details
This is a "connection" page, showing publications John Moroney has written about Paclitaxel.
John Moroney
Connection Strength
0.203
Paclitaxel
  1. An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer (PROFECTA-II/GOG-3044). Gynecol Oncol. 2025 Mar; 194:145-152.
    View in: PubMed
    Score: 0.203
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.